Evolution of LC–MS/MS in clinical laboratories

Songlin Yu,Yutong Zou,Xiaoli Ma,Danchen Wang,Wei Luo,Yueming Tang,Danni Mu,Ruiping Zhang,Xinqi Cheng,Ling Qiu
DOI: https://doi.org/10.1016/j.cca.2024.117797
IF: 6.314
2024-01-28
Clinica Chimica Acta
Abstract:Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has attracted significant attention as an analytical tool due to its ability to unequivocally identify and quantitate biomarkers of interest. However, the widespread adoption of this technology in clinical practice has been hindered by certain limitations, such as analyte selection, low levels of automation, expense, lack of specific reference intervals and quality control programs. Furthermore, harmonization and standardization of current and future methods are needed. This review provides a comprehensive in-depth analysis of these current challenges and examines potential resolutions. It is clear that additional work is needed to enable the seamless integration of this evolving LC-MS/MS technology in routine clinical practice.
medical laboratory technology
What problem does this paper attempt to address?